The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indication of bioavailability: a comparative study.
Sidney J StohsC Y O ChenHarry G PreussSidhartha D RayLuke R BucciJin JiKevin J RuffPublished in: BMC complementary and alternative medicine (2019)
ClinicalTrails.gov, trial identifying number NCT04103788 , September 24, 2019. Retrospectively registered.